TAOK3
Basic information
Region (hg38): 12:118149801-118372907
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAOK3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 33 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 34 | 0 | 2 |
Variants in TAOK3
This is a list of pathogenic ClinVar variants found in the TAOK3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-118151058-C-T | not specified | Uncertain significance (Jun 26, 2023) | ||
12-118151125-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
12-118152332-G-A | Benign (Mar 29, 2018) | |||
12-118160160-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
12-118160353-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
12-118160365-A-G | Likely benign (Aug 16, 2018) | |||
12-118161927-A-G | not specified | Uncertain significance (Feb 07, 2023) | ||
12-118172483-C-T | not specified | Uncertain significance (Mar 21, 2023) | ||
12-118172524-T-C | not specified | Uncertain significance (Mar 23, 2023) | ||
12-118172552-T-A | not specified | Uncertain significance (Dec 30, 2023) | ||
12-118172559-G-C | not specified | Uncertain significance (Dec 30, 2023) | ||
12-118172617-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
12-118177217-T-G | not specified | Uncertain significance (Jun 29, 2022) | ||
12-118177274-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
12-118177322-A-G | not specified | Uncertain significance (May 27, 2022) | ||
12-118181441-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
12-118181535-G-A | not specified | Uncertain significance (May 04, 2022) | ||
12-118181610-G-A | Likely benign (Dec 31, 2019) | |||
12-118189826-G-A | not specified | Uncertain significance (Jun 21, 2021) | ||
12-118199098-C-T | not specified | Uncertain significance (Mar 28, 2023) | ||
12-118199105-C-T | not specified | Uncertain significance (May 07, 2024) | ||
12-118199223-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
12-118199235-AG-A | Neurodevelopmental disorder | Uncertain significance (Jun 28, 2021) | ||
12-118201313-A-G | not specified | Uncertain significance (May 25, 2022) | ||
12-118201359-C-A | not specified | Uncertain significance (Apr 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAOK3 | protein_coding | protein_coding | ENST00000392533 | 19 | 223145 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000254 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.03 | 313 | 505 | 0.620 | 0.0000293 | 6009 |
Missense in Polyphen | 47 | 119.48 | 0.39339 | 1425 | ||
Synonymous | 0.767 | 169 | 182 | 0.928 | 0.0000106 | 1566 |
Loss of Function | 5.97 | 7 | 54.6 | 0.128 | 0.00000302 | 623 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000391 | 0.0000391 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000979 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress- activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF). {ECO:0000269|PubMed:10559204, ECO:0000269|PubMed:10924369, ECO:0000269|PubMed:17396146}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Core;MAPK Signaling Pathway;p38 MAPK signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.177
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.46
Haploinsufficiency Scores
- pHI
- 0.400
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Taok3
- Phenotype
Gene ontology
- Biological process
- MAPK cascade;activation of MAPKK activity;DNA repair;protein phosphorylation;negative regulation of protein kinase activity;cellular response to DNA damage stimulus;mitotic G2 DNA damage checkpoint;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;positive regulation of stress-activated MAPK cascade;positive regulation of JUN kinase activity;negative regulation of JNK cascade;positive regulation of JNK cascade;protein autophosphorylation
- Cellular component
- nucleus;cytoplasm;plasma membrane
- Molecular function
- protein serine/threonine kinase activity;MAP kinase kinase kinase activity;protein kinase inhibitor activity;protein binding;ATP binding;transferase activity